Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Japanese Journal of Clinical Oncology|August 21, 2018
Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapyHironobu Hashimoto, Masakazu Abe, Takako Yanai, et al.
International Journal of Clinical Oncology|March 15, 2012
Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancerNatsuko Hori, Satoru Iwasa, Hironobu Hashimoto, et al.
International Journal of Hematology|March 28, 2019
Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantationToshihisa Nakashima, Takashi Tanaka, Keiichi Koido, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 23, 2020
Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case reportHideyuki Hibino, Yoshinori Makino, Naomi Sakiyama, et al.
Japanese Journal of Clinical Oncology|April 28, 2009
Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trialMasahito Yonemura, Noriyuki Katsumata, Hironobu Hashimoto, et al.
Japanese Journal of Clinical Oncology|November 9, 2012
A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruptionHironobu Hashimoto, Satoru Iwasa, Takako Yanai, et al.
Anticancer Research|May 27, 2026
The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib TherapyKeisuke Ikegami, Reiko Ando Makihara, Yuki Shinno, et al.
Asia-Pacific Journal of Clinical Oncology|August 7, 2015
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patientsTetsuji Terazawa, Hitoshi Nishitani, Ken Kato, et al.
Anticancer Research|January 30, 2022
Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With OsteosarcomaKentaro Abe, Ayako Maeda-Minami, Taku Ishizu, et al.
BMJ Open|March 3, 2022
Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)Rie Ozeki, Hirotoshi Iihara, Mototsugu Shimokawa, et al.
Pageof 8